These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9648787)

  • 1. Posttransplantation lymphoproliferative disorder of the liver.
    Pena CS; Chew FS; Keel SB
    AJR Am J Roentgenol; 1998 Jul; 171(1):192. PubMed ID: 9648787
    [No Abstract]   [Full Text] [Related]  

  • 2. Posttransplantation lymphoproliferative disorder: osseous and hepatic involvement.
    Kaushik S; Fulcher AS; Frable WJ; May DA
    AJR Am J Roentgenol; 2001 Nov; 177(5):1057-9. PubMed ID: 11641168
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignant tumors under immunosuppression, a new problem in transplant-recipients].
    Enderlin F; Guisan Y
    Helv Chir Acta; 1973 Dec; 40(5):773-6. PubMed ID: 4589045
    [No Abstract]   [Full Text] [Related]  

  • 4. Extranodal diffuse large B-cell lymphoma confined to liver in a kidney transplant recipient.
    Makhdoomi K; Ghaffari Moghaddam A; Aishi Oskue A; Mohammadi A; Ilkhanizadeh B; Enshae A; Shateri K; Esmaeli A
    Iran J Kidney Dis; 2010 Oct; 4(4):336-9. PubMed ID: 20852378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post liver transplantation lymphoproliferative disorder mimics recurrence of hepatocellular carcinoma.
    Poovorawan K; Linlawan S; Wisedopas N; Komolmit P
    BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24351512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monotherapy with anti-CD20 monoclonal antibody in a heart transplant recipient with sick sinus syndrome and posttransplantation lymphoproliferative disorder: a case report.
    Yang HY; Ke HY; Hong GJ; Tsai YT; Lin CY; Li CY; Tsai CS
    Heart Surg Forum; 2009 Oct; 12(5):E300-2. PubMed ID: 19833600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant tumours following immunosuppression in renal transplantation.
    Birkeland SA; Kemp E
    Proc Eur Dial Transplant Assoc; 1973; 10(0):429-33. PubMed ID: 4370181
    [No Abstract]   [Full Text] [Related]  

  • 8. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
    Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG
    J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransplantation lymphoproliferative disorder in the knee.
    Pineda R; Wyard L; Tietjen R; Sieber S
    Clin Orthop Relat Res; 1998 May; (350):195-200. PubMed ID: 9602820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
    Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
    Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat.
    Smeltzer JP; Viswanatha DS; Habermann TM; Patnaik MM
    Am J Hematol; 2012 Sep; 87(9):927-8. PubMed ID: 22718468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brief report: lymphoma of donor origin occurring in the porta hepatis of a transplanted liver.
    Spiro IJ; Yandell DW; Li C; Saini S; Ferry J; Powelson J; Katkov WN; Cosimi AB
    N Engl J Med; 1993 Jul; 329(1):27-9. PubMed ID: 8505941
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemochromatosis.
    Palazzo JP; Lundquist K; Mitchell D; Mittal KR; Hann HW; Munoz S; Moritz MJ; Jacobs JM; Martin P
    Am J Gastroenterol; 1993 Jan; 88(1):102-4. PubMed ID: 8380533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-onset post-transplant lymphoproliferative disease presenting as massive occult gastrointestinal haemorrhage.
    Chia SC; Chau YP; Tan YM
    Singapore Med J; 2008 May; 49(5):e117-20. PubMed ID: 18465033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of bone marrow and liver biopsy in malignant lymphomas (author's transl)].
    Güller R; Senn HJ; Nagel GA; Gudat F; Gyr K
    Schweiz Rundsch Med Prax; 1973 Dec; 62(51):1583-5. PubMed ID: 4589067
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the intra-vitam diagnosis of primary sarcoma of the liver].
    Dell'Acqua G
    Rass Clin Ter; 1966; 65(5):239-49. PubMed ID: 5340919
    [No Abstract]   [Full Text] [Related]  

  • 17. Sirolimus addition to tacrolimus-based immunosuppression induces complete remission of post-transplant lymphoproliferative disorder in a liver transplant recipient.
    Staufer K; Sterneck M; Schaefer H; Nashan B; Fischer L
    Transpl Int; 2010 Oct; 23(10):1068-70. PubMed ID: 20536793
    [No Abstract]   [Full Text] [Related]  

  • 18. [Loss of general status and liver mass in a 56 year-old man].
    de la Mata García M; Nadal A
    Med Clin (Barc); 1997 Oct; 109(11):431-6. PubMed ID: 9379735
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppression and malignancy.
    Br Med J; 1972 Sep; 3(5829):713-4. PubMed ID: 4562175
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical variants and masks of reticulosarcomatosis with abdominal localization].
    Gordon IB; Mishchenko GA
    Ter Arkh; 1972 Nov; 44(11):67-71. PubMed ID: 4579744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.